HERS

Hers

(ārz),

G., French biochemist. See: Hers disease.

AIDS HIV Epidemiology Research Study. A multisite, prospective cohort study of HIV-infected women and uninfected women reporting HIV risk behaviour
Conclusion Although both HIV-seropositive and HIV-seronegative women had high levels of use of medical services, current use of antiretrovirals and OI prophylaxis was low throughout. Therapeutic drug users used HIV-related primary health services less and were more likely to receive emergency or episodic care. IV drug users and African Americans had decreased use of medical services
Cardiology Heart and Estrogen/progestin
Replacement Study A randomized, placebo controlled clinical trial which showed that in women average age 67 with known (preexisting) coronary artery disease, mortality was increased at one year of E/P therapy and decreased thereafter. A follow-up study found that patients receiving HMG-CoA-reductase inhibitors had the same levels of coronary events as patients taking placebos

HERS

AIDS A study–HIV Epidemiology Research Study Cardiology A randomized, placebo controlled clinical trial–Heart & Estrogen/Progestin Replacement Study–which showed that in ♀ average age 67 with known/preexisting CAD, mortality due to acute MIs, stroke, and hypercoagulation was ↑ with E/P therapy. See Study, Trial.